United States· US:0591-3222_76bd2057-e1ac-4529-9663-f6139218eeab
Orphenadrine Citrate
A medicinal product containing orphenadrine citrate, registered in United States by Actavis Pharma, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ORPHENADRINE CITRATE
- Manufacturer
- Actavis Pharma, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11059132224710 AMPULE in 1 CARTON (0591-3222-47) / 2 mL in 1 AMPULE (0591-3222-02)
- ndc110591-3222-47
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Orphenadrine citrate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBiorphen 25mg/5ml oral solutionRosemont Pharmaceuticals Ltd
- FinlandNorflexParanova Oy
- NorwayDisipalAstellas Pharma AS
- GermanyNorflexViatris Healthcare Gmbh
- ItalyDISIPAL*50 cpr rivestite 50 mgECUPHARMA Srl
- CanadaSANDOZ ORPHENADRINESANDOZ CANADA INCORPORATED
- SwedenNorflex 100 mg DepottablettViatris AB
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Norflex, Norflex N
- Denmark · Lysantin
- Finland · Norflex
- United Kingdom (Northern Ireland) · Orphenadrine Hydrochloride Rosemont Pharmaceuticals
- Greece · Orphedrin
- Italy · Disipal
- Sweden · Norflex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ddadd4b1-e17c-4cd0-9fa2-7b278c72e6cf GET /v1/drugs/ddadd4b1-e17c-4cd0-9fa2-7b278c72e6cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR; INTRAVENOUS",
"source": "ndc",
"strength": "30",
"substance": "ORPHENADRINE CITRATE",
"productndc": "0591-3222",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA084779",
"marketing_category": "ANDA"
}See everything about orphenadrine citrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.